Profile
Full Name
Alnylam Pharmaceuticals, Inc.Ticker
NASDAQ: ALNYExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 1, 2004Indexes
Not includedWebsite
https://www.alnylam.comEmployees
2230Key Details
Price
$401.80(+2.44%)
Market cap
$52.67B(Large cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$2.25B(+22.97% YoY)
Annual EPS
-$2.18(+38.07% YoY)
Next earnings date
Oct 31, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Alnylam Pharmaceuticals, Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 1, 25 Wells Fargo
Equal-WeightAug 1, 25 UBS
BuyAug 1, 25 Scotiabank
Sector OutperformAug 1, 25 Raymond James
OutperformAug 1, 25 Piper Sandler
OverweightAug 1, 25 Morgan Stanley
Equal-WeightAug 1, 25 Chardan Capital
BuyAug 1, 25 Canaccord Genuity
BuyAug 1, 25 Barclays
OverweightJul 31, 25 Needham
BuyInstitutional Ownership
- What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
- Does Alnylam Pharmaceuticals, Inc. pay dividends?
- What sector is Alnylam Pharmaceuticals, Inc. in?
- What industry is Alnylam Pharmaceuticals, Inc. in?
- What country is Alnylam Pharmaceuticals, Inc. based in?
- When did Alnylam Pharmaceuticals, Inc. go public?
- Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
- Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
- Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
- When was Alnylam Pharmaceuticals, Inc.'s last earnings report?
- When does Alnylam Pharmaceuticals, Inc. report earnings?
What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?
The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY
Does Alnylam Pharmaceuticals, Inc. pay dividends?
No, Alnylam Pharmaceuticals, Inc. does not pay dividends
What sector is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Alnylam Pharmaceuticals, Inc. in?
Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Alnylam Pharmaceuticals, Inc. based in?
Alnylam Pharmaceuticals, Inc. is headquartered in United States
When did Alnylam Pharmaceuticals, Inc. go public?
Alnylam Pharmaceuticals, Inc.'s initial public offering (IPO) was on June 1, 2004
Is Alnylam Pharmaceuticals, Inc. in the S&P 500?
No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?
No, Alnylam Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?
No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Alnylam Pharmaceuticals, Inc.'s last earnings report?
Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on July 31, 2025
When does Alnylam Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Alnylam Pharmaceuticals, Inc. is October 31, 2025